Companies included in CANC
This is CANC's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–56 of 56.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | 98,581 | NS | 6.290585% |
| NOVN | Novartis AG | 46,684 | NS | 4.956208% |
| BBIO | Bridgebio Pharma Inc | 114,318 | NS | 4.753551% |
| AZN | AstraZeneca PLC | 35,320 | NS | 4.627204% |
| LLY | Eli Lilly & Co | 6,565 | NS | 4.319753% |
| BMY | Bristol-Myers Squibb Co | 108,187 | NS | 4.220495% |
| RHHBY | Roche Holding AG | 108,952 | NS | 4.058163% |
| MRK | Merck & Co Inc | 49,630 | NS | 3.843683% |
| ACLX | Arcellx Inc | 48,346 | NS | 3.440941% |
| COGT | Cogent Biosciences Inc | 135,358 | NS | 3.289179% |
| NUVL | Nuvalent Inc | 49,239 | NS | 3.139851% |
| GMAB | Genmab A/S | 169,724 | NS | 3.125314% |
| IMNM | Immunome Inc | 195,451 | NS | 2.672395% |
| JNJ | Johnson & Johnson | 16,257 | NS | 2.526137% |
| CELC | Celcuity Inc | 35,371 | NS | 2.471451% |
| AMGN | Amgen Inc | 10,122 | NS | 2.457478% |
| ABBV | AbbVie Inc | 16,712 | NS | 2.425932% |
| EXEL | Exelixis Inc | 79,639 | NS | 2.194739% |
| IDYA | Ideaya Biosciences Inc | 89,238 | NS | 1.79729% |
| ONC | BeOne Medicines Ltd | 8,960 | NS | 1.776504% |
| SNDX | Syndax Pharmaceuticals Inc | 127,353 | NS | 1.729345% |
| CGON | CG oncology Inc | 45,885 | NS | 1.687565% |
| ZLAB | Zai Lab Ltd | 121,279 | NS | 1.45798% |
| ERAS | Erasca Inc | 169,487 | NS | 1.448104% |
| ZYME | Zymeworks Inc | 96,723 | NS | 1.409003% |
| LEGN | Legend Biotech Corp | 115,409 | NS | 1.371532% |
| NUVB | Nuvation Bio Inc | 362,046 | NS | 1.338332% |
| HALO | Halozyme Therapeutics Inc | 29,868 | NS | 1.298945% |
| 4519 | Chugai Pharmaceutical Co Ltd | 30,652 | NS | 1.283547% |
| SMMT | Summit Therapeutics Inc | 110,918 | NS | 1.150962% |
| ANAB | AnaptysBio Inc | 28,657 | NS | 0.986735% |
| NRIX | Nurix Therapeutics Inc | 97,555 | NS | 0.974467% |
| REGN | Regeneron Pharmaceuticals Inc | 1,982 | NS | 0.969035% |
| CRVS | Corvus Pharmaceuticals Inc | 82,148 | NS | 0.938232% |
| URGN | UroGen Pharma Ltd | 67,164 | NS | 0.911609% |
| RLAY | Relay Therapeutics Inc | 142,040 | NS | 0.911529% |
| GILD | Gilead Sciences Inc | 9,272 | NS | 0.863826% |
| OLMA | Olema Pharmaceuticals Inc | 56,608 | NS | 0.856852% |
| DAWN | Day One Biopharmaceuticals Inc | 121,928 | NS | 0.808392% |
| ARGX | Argenx SE | 1,663 | NS | 0.797728% |
| TERN | Terns Pharmaceuticals Inc | 28,018 | NS | 0.738139% |
| FXFXX | First American Treasury Obliga | 1,026,900.56 | NS | 0.642304% |
| XNCR | Xencor Inc | 76,928 | NS | 0.614452% |
| TYRA | Tyra Biosciences Inc | 28,438 | NS | 0.592497% |
| GH | Guardant Health Inc | 10,008 | NS | 0.587794% |
| RCUS | Arcus Biosciences Inc | 45,953 | NS | 0.585487% |
| AVBP | ArriVent Biopharma Inc | 40,743 | NS | 0.585365% |
| IMCR | Immunocore Holdings PLC | 28,275 | NS | 0.571239% |
| HCM | HUTCHMED China Ltd | 62,129 | NS | 0.556869% |
| GLUE | Monte Rosa Therapeutics Inc | 45,524 | NS | 0.505419% |
| CGEM | Cullinan Therapeutics Inc | 47,065 | NS | 0.456291% |
| CMPX | Compass Therapeutics Inc | 127,476 | NS | 0.450494% |
| JANX | Janux Therapeutics Inc | 47,193 | NS | 0.401743% |
| NTRA | Natera Inc | 3,049 | NS | 0.39675% |
| ARVN | Arvinas Inc | 45,326 | NS | 0.37621% |
| ORIC | ORIC Pharmaceuticals Inc | 35,407 | NS | 0.297868% |
SEC N-PORT snapshot as of .